Home › Funds › SOFTBANK GROUP CORP. › ABCL
SOFTBANK GROUP CORP. position in ABCL
ABCELLERA BIOLOGICS INC · Health Care
SOFTBANK GROUP CORP. reported holding 172,581 shares of ABCL (ABCELLERA BIOLOGICS INC) in its Q3 2026 13F filing — a position valued at US$2.5M, representing 0.02% of its reported portfolio and ranking #25 among its reported holdings. SOFTBANK GROUP CORP. has disclosed ABCL holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How SOFTBANK GROUP CORP.'s ABCL position evolved
SOFTBANK GROUP CORP. first disclosed a stake in ABCL in Q4 2025 at 345,161 shares (US$1.2M). The position peaked in Q2 2026 at 345,161 shares, worth US$2.7M. Across 4 filings, SOFTBANK GROUP CORP. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 172,581 shares valued at US$2.5M — a reduction of -172,580 shares quarter over quarter.. Notable position changes include a 50% trim in Q3 2026 (shares fell 21% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 345.16K | $1.18M | New |
| Q1 2026 | 345.16K | $1.20M | Hold |
| Q2 2026 | 345.16K | $2.71M | Hold |
| Q3 2026 | 172.58K | $2.52M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABCL and 13F data
ABCL (ABCELLERA BIOLOGICS INC) is a Health Care company. 46 other funds we track also report a position in ABCL — the largest reported positions include BAKER BROS. ADVISORS LP (US$259.1M), ArrowMark Colorado Holdings LLC (US$70.4M), ADAR1 Capital Management, LLC (US$12.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABCL
- BAKER BROS. ADVISORS LP 33.01M sh · $259.15M · Q2 2026
- ArrowMark Colorado Holdings LLC 4.82M sh · $70.37M · Q3 2026
- ADAR1 Capital Management, LLC 822.16K sh · $12.00M · Q3 2026
- Guardian Partners Inc. 596.00K sh · $8.70M · Q3 2026
- Intellectus Partners, LLC 584.13K sh · $8.52M · Q3 2026
- Informed Momentum Co LLC 446.19K sh · $6.51M · Q3 2026
- Global IMC LLC 278.90K sh · $4.07M · Q3 2026
More on SOFTBANK GROUP CORP.
FAQ
How long has SOFTBANK GROUP CORP. held ABCL?
SOFTBANK GROUP CORP. has disclosed ABCL holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is SOFTBANK GROUP CORP.'s current position in ABCL?
As of Q3 2026, SOFTBANK GROUP CORP. holds 172.58K shares of ABCL (ABCELLERA BIOLOGICS INC), valued at $2.52M, representing 0.02% of its reported portfolio and ranking #25.
Has SOFTBANK GROUP CORP. been buying or selling ABCL?
In the latest 13F filing (Q3 2026), SOFTBANK GROUP CORP. reduced its position in ABCL. The position peaked in Q2 2026 at 345.16K shares.
Which other funds hold ABCL?
Other major institutional holders of ABCL include BAKER BROS. ADVISORS LP, ArrowMark Colorado Holdings LLC, ADAR1 Capital Management, LLC, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.